Charting Regulatory Shifts in CGT: Decisions, Innovation & What’s Next

• Summarizing trends in recent CGT FDA decisions
• Sharing new tools and platform technologies of interest at the FDA
• Diving into FDA trends and future direction

Speakers:

Sharon Anderson

Vice President, Scientific Affairs

Alliance for Regenerative Medicine